SubscribeElsewhere on HealthThreads: Lymphoma | Thyroid cancer | Overactive bladder | Stomach cancer |
# 2 News Source
Medical News Today
Medical News Today (www.medicalnewstoday.com) has great Bladder cancer news, photos, videos and more
Friday, Dec 4
What Is Schistosomiasis (Bilharzia)? What Causes Schistosomiasis (Bilharzia)?
When the urinary system is infected there is a significantly higher risk in adults of developing bladder cancer. Schistosomiasis may infect the ...
TARIS Successfully Completes Phase 1 Study - Medical News Today
TARIS Successfully Completes Phase 1 Study press release) These diseases include interstitial cystitis (IC)/painful bladder syndrome (PBS), bladder cancer, overactive bladder, urinary tract infections and chronic ...
Thursday, Dec 3
Predictive Biosciences Presents Novel Multi-Analyte Approach To Diagnostic ... - Medical News Today
Predictive Biosciences Presents Novel Multi-Analyte Approach To Diagnostic ... press release) FGFR3 gene mutations, detectable in the urine of bladder cancer patients, have been shown to be associated with early stage/early grade bladder cancer with ... and more »
Monday, Nov 30
The Effect Of On-Line Position Correction On The Dose Distribution In Focal ... - Medical News Today
The Effect Of On-Line Position Correction On The Dose Distribution In Focal ... press release) Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer. Strahlenther Onkol 2008;184:313-318. ...
Sunday, Aug 2
Outcomes Of Patients Undergoing Radical Cystoprostatectomy For Bladder Cancer With Prostatic Involvement On Final ...
UroToday.com - Urothelial carcinoma (UC) can invade the prostate in men with bladder cancer. In fact, it is found in 15%-48% of cystoprostatectomy specimens from patients with bladder cancer.
Wednesday, Jul 22
FDA Designates Fast Track Status For Apaziquone (EOquin(R)) For Bladder Cancer
Spectrum Pharmaceuticals (NasdaqGM: SPPI) and Allergan, Inc. (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for the investigation of apaziquone (EOquin®) for the treatment of non-muscle invasive bladder cancer, a form...
Monday, Jun 22
The Use Of Short Tandem Repeat Profiling To Characterize Human Bladder Cancer Cell Lines
UroToday.com - My laboratory established a series of urothelial cancer cell lines at the University of Michigan. Having worked with them for more than 2 decades, I became aware of some inconsistencies in results. This led to defining the genomic signature of the cell lines to assure that co...
Monday, Jun 8
Bladder Cancer - Molecular Analyte Profiling Of Early Events & Tissue Conditioning Following Intravesical Bacillus ...
UroToday.com - Since the work of Morales et al. in 1976, BCG therapy has been the standard of care for superficial transitional cell carcinoma. Although it has been shown that BCG instillations triggers Th1-mediated responses in patients, the precise mechanism(s) leading to the observe...
Friday, May 29
BioCis Pharma Starts A Phase I Clinical Trial With A New Cancer Drug
BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, has started Phase I clinical testing of ProtoCure(TM) intravesical instillation solution, a novel anti-cancer drug for urinary bladder cancer.
Friday, May 15
Inventors Develop Novel Technique To Help Customize, Enhance The Effectiveness Of Bladder Cancer Treatment
Researchers in the University of Virginia Department of Urology have developed a novel method that could help physicians determine the best course of treatment for patients suffering from bladder cancer.
Tuesday, Apr 21
Genetic Variants Predict Recurrence Of Bladder Cancer, Patient Survival
Scientists at The University of Texas M. D. Anderson Cancer Center have discovered genetic variations in the inflammation pathway that reduce the likelihood of recurrence and increase survival of patients with non-muscle invasive bladder cancer (NMIBC) who are treated with mainstre...
Saturday, Apr 11
More Intensive Treatment Not Associated With Better Outcomes In Early Bladder Cancer
Patients with early bladder cancer who receive more intensive treatment within the first two years of diagnosis do not appear to have better survival than patients who receive less intensive treatment, according to a retrospective analysis published in the April 7 online issue of the...
Monday, Mar 30
Bladder Cancer SNP Panel Predicts Susceptibility And Survival
UroToday.com - Bladder cancer is a common GU tumor that has clear genetic basis regarding formation and progression. Chromosomal abnormalities on 5, 7, and 9 have been associated with tumor formation and or progression. These authors evaluated the role of single nucleotide polymorphis...
